Skip to main content
Be The Investor
Home›Stocks›APLS
APLS

Apellis Pharmaceuticals, Inc.

APLS
NASDAQUnited States flagUSReal-Time Price
$41.03USD
0.00 (0.00%)Today
BTI Score
Near Future
54
Long Term
62
BTI Fair Market Cap
$3.19B
+64.47% vs fair
Biotechnology
Hold

Apellis Pharmaceuticals, Inc. (APLS) Forecast & Price Targets

Review available Apellis Pharmaceuticals, Inc. (APLS) analyst price targets and compare them with earnings and valuation. Analyst targets are separate from BTI scores; missing data is marked unavailable.

APLS stock forecast and analyst price targets

Analyst price targets estimate possible future share prices. They are separate from BTI scores and fair-value models. The highest and lowest targets describe the provider's range, not the probability of a bull or bear scenario.

APLS targets — Financial Modeling Prep — price-target-consensus. Target publication dates and investment horizons are not supplied by this feed.
MeasureTarget (USD)Difference from available quote
Highest analyst target83.00+102.3%
Consensus analyst target83.00+102.3%
Lowest analyst target83.00+102.3%

The comparison uses the available quote, which may be delayed. It is not an expected return over a specified period.

How should I evaluate the APLS forecast?

Compare the targets with reported earnings, cash flow, valuation assumptions and company risks. A price target alone does not determine whether an investment is suitable.